Grifols SA (GRFS)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current GRFS market cap is 5.4B. The company's latest EPS is EUR 0.0863 and P/E is 110.66.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 1.6B | 1.77B | 1.63B | 1.82B | 1.79B |
| Operating Income | -462.64M | -758.69M | 203.66M | -39.73M | -349.35M |
| Net Income | 59.54M | 56M | 21.42M | 14.84M | 51.69M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 5.15B | 5.39B | 5B | 6.06B | 6.59B |
| Operating Income | 1.09B | 1.06B | 628.25M | 804.2M | 798.48M |
| Net Income | 625.15M | 618.55M | 182.8M | 208.28M | 59.32M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 22.06B | 21.44B | 21.95B | 22.29B | 20.28B |
| Total Liabilities | 13.5B | 13.47B | 13.83B | 14B | 12.29B |
| Total Equity | 8.57B | 7.97B | 8.12B | 8.3B | 8B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 15.54B | 15.27B | 19.23B | 21.53B | 21.44B |
| Total Liabilities | 8.7B | 8.55B | 11.09B | 13.08B | 13.47B |
| Total Equity | 6.85B | 6.72B | 8.15B | 8.46B | 7.97B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 51.9M | 208.28M | -164.92M | 87.94M | 387.55M |
| Investing | -255.76M | -397.64M | -87.95M | 1.26B | 1.06B |
| Financing | 139.57M | 186.05M | 165.46M | 224.9M | -1.33B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 568.93M | 1.11B | 596.98M | -10.87M | 208.28M |
| Investing | -548.79M | -858.12M | -29.39M | -1.98B | -397.64M |
| Financing | -332.36M | -354.4M | 1.47B | -173.49M | 186.05M |
| Market Cap | 5.4B |
| Price to Earnings Ratio | 110.66 |
| Price to Sales Ratio | 1 |
| Price to Cash Ratio | 12.4 |
| Price to Book Ratio | 0.82 |
| Dividend Yield | - |
| Shares Outstanding | 687.55M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.59 (7.33%) |
| Company Name | Grifols SA |
| Address |
calle jesus i maria, 6 barcelona, catalonia 08174 |
| Website | https://www.grifols.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
